329 related articles for article (PubMed ID: 16757329)
41. Raf kinase inhibitor protein affects activity of Plasmodium falciparum calcium-dependent protein kinase 1.
Kugelstadt D; Winter D; Plückhahn K; Lehmann WD; Kappes B
Mol Biochem Parasitol; 2007 Jan; 151(1):111-7. PubMed ID: 17123645
[TBL] [Abstract][Full Text] [Related]
42. Raf kinase inhibitor protein interacts with NF-kappaB-inducing kinase and TAK1 and inhibits NF-kappaB activation.
Yeung KC; Rose DW; Dhillon AS; Yaros D; Gustafsson M; Chatterjee D; McFerran B; Wyche J; Kolch W; Sedivy JM
Mol Cell Biol; 2001 Nov; 21(21):7207-17. PubMed ID: 11585904
[TBL] [Abstract][Full Text] [Related]
43. Suppression of Raf-1 kinase activity and MAP kinase signalling by RKIP.
Yeung K; Seitz T; Li S; Janosch P; McFerran B; Kaiser C; Fee F; Katsanakis KD; Rose DW; Mischak H; Sedivy JM; Kolch W
Nature; 1999 Sep; 401(6749):173-7. PubMed ID: 10490027
[TBL] [Abstract][Full Text] [Related]
44. Development and implementation of three mitogen-activated protein kinase (MAPK) signaling pathway imaging assays to provide MAPK module selectivity profiling for kinase inhibitors: MK2-EGFP translocation, c-Jun, and ERK activation.
Nickischer D; Laethem C; Trask OJ; Williams RG; Kandasamy R; Johnston PA; Johnston PA
Methods Enzymol; 2006; 414():389-418. PubMed ID: 17110204
[TBL] [Abstract][Full Text] [Related]
45. Effects of raf kinase inhibitor protein expression on metastasis and progression of human breast cancer.
Li HZ; Gao Y; Zhao XL; Liu YX; Sun BC; Yang J; Yao Z
Mol Cancer Res; 2009 Jun; 7(6):832-40. PubMed ID: 19531568
[TBL] [Abstract][Full Text] [Related]
46. Raf kinase inhibitor protein correlates with sensitivity of nasopharyngeal carcinoma to radiotherapy.
Ruan L; Wang GL; Yi H; Chen Y; Tang CE; Zhang PF; Li MY; Li C; Peng F; Li JL; Chen ZC; Xiao ZQ
J Cell Biochem; 2010 Jul; 110(4):975-81. PubMed ID: 20564197
[TBL] [Abstract][Full Text] [Related]
47. American ginseng (Panax quinquefolius L.) extract alters mitogen-activated protein kinase cell signaling and inhibits proliferation of MCF-7 cells.
King ML; Murphy LL
J Exp Ther Oncol; 2007; 6(2):147-55. PubMed ID: 17407973
[TBL] [Abstract][Full Text] [Related]
48. Ras-mediated intestinal epithelial cell transformation requires cyclooxygenase-2-induced prostaglandin E2 signaling.
Repasky GA; Zhou Y; Morita S; Der CJ
Mol Carcinog; 2007 Dec; 46(12):958-70. PubMed ID: 17477350
[TBL] [Abstract][Full Text] [Related]
49. Identification of key residues in the A-Raf kinase important for phosphoinositide lipid binding specificity.
Johnson LM; James KM; Chamberlain MD; Anderson DH
Biochemistry; 2005 Mar; 44(9):3432-40. PubMed ID: 15736953
[TBL] [Abstract][Full Text] [Related]
50. Spatial regulation of Raf kinase signaling by RKTG.
Feng L; Xie X; Ding Q; Luo X; He J; Fan F; Liu W; Wang Z; Chen Y
Proc Natl Acad Sci U S A; 2007 Sep; 104(36):14348-53. PubMed ID: 17724343
[TBL] [Abstract][Full Text] [Related]
51. RKTG sequesters B-Raf to the Golgi apparatus and inhibits the proliferation and tumorigenicity of human malignant melanoma cells.
Fan F; Feng L; He J; Wang X; Jiang X; Zhang Y; Wang Z; Chen Y
Carcinogenesis; 2008 Jun; 29(6):1157-63. PubMed ID: 18515281
[TBL] [Abstract][Full Text] [Related]
52. Raf kinase inhibitor protein (RKIP) in cancer.
Escara-Wilke J; Yeung K; Keller ET
Cancer Metastasis Rev; 2012 Dec; 31(3-4):615-20. PubMed ID: 22684368
[TBL] [Abstract][Full Text] [Related]
53. Targeting the Raf/MEK/ERK pathway with small-molecule inhibitors.
McCubrey JA; Milella M; Tafuri A; Martelli AM; Lunghi P; Bonati A; Cervello M; Lee JT; Steelman LS
Curr Opin Investig Drugs; 2008 Jun; 9(6):614-30. PubMed ID: 18516761
[TBL] [Abstract][Full Text] [Related]
54. Involvement of Ras/Raf-1/ERK actions in the magnolol-induced upregulation of p21 and cell-cycle arrest in colon cancer cells.
Hsu YF; Lee TS; Lin SY; Hsu SP; Juan SH; Hsu YH; Zhong WB; Lee WS
Mol Carcinog; 2007 Apr; 46(4):275-83. PubMed ID: 17295239
[TBL] [Abstract][Full Text] [Related]
55. The RKIP (Raf-1 Kinase Inhibitor Protein) conserved pocket binds to the phosphorylated N-region of Raf-1 and inhibits the Raf-1-mediated activated phosphorylation of MEK.
Rath O; Park S; Tang HH; Banfield MJ; Brady RL; Lee YC; Dignam JD; Sedivy JM; Kolch W; Yeung KC
Cell Signal; 2008 May; 20(5):935-41. PubMed ID: 18294816
[TBL] [Abstract][Full Text] [Related]
56. Activation of extracellular signal-regulated kinase during silibinin-protected, isoproterenol-induced apoptosis in rat cardiac myocytes is tyrosine kinase pathway-mediated and protein kinase C-dependent.
Zhou B; Wu LJ; Tashiro S; Onodera S; Uchiumi F; Ikejima T
Acta Pharmacol Sin; 2007 Jun; 28(6):803-10. PubMed ID: 17506939
[TBL] [Abstract][Full Text] [Related]
57. Induction of Raf kinase inhibitor protein contributes to macrophage differentiation.
Schuierer MM; Heilmeier U; Boettcher A; Ugocsai P; Bosserhoff AK; Schmitz G; Langmann T
Biochem Biophys Res Commun; 2006 Apr; 342(4):1083-7. PubMed ID: 16513087
[TBL] [Abstract][Full Text] [Related]
58. A chemical inhibitor reveals the role of Raf kinase inhibitor protein in cell migration.
Zhu S; Mc Henry KT; Lane WS; Fenteany G
Chem Biol; 2005 Sep; 12(9):981-91. PubMed ID: 16183022
[TBL] [Abstract][Full Text] [Related]
59. Investigating dynamics of inhibitory and feedback loops in ERK signalling using power-law models.
Vera J; Rath O; Balsa-Canto E; Banga JR; Kolch W; Wolkenhauer O
Mol Biosyst; 2010 Nov; 6(11):2174-91. PubMed ID: 20717620
[TBL] [Abstract][Full Text] [Related]
60. Raf kinase inhibitor protein mediated signaling inhibits invasion and metastasis of hepatocellular carcinoma.
Wu X; Yang Y; Xu Z; Li J; Yang B; Feng N; Zhang Y; Wang S
Biochim Biophys Acta; 2016 Feb; 1860(2):384-91. PubMed ID: 26116914
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
